VTRS News and Press, Viatris Inc.

2026-02-27 16:18:00 ET Investment Thesis Read the full article on Seeking Alpha For further details see: IHE: U.S. Pharmaceuticals ETF With Excellent GARP Features

2026-02-27 15:57:23 ET On February 6, 2026, Bastion Asset Management disclosed a new position in Parsons (NYSE:PSN) , acquiring 128,186 shares in the fourth quarter—an estimated $8.04 million trade based on quarterly average pricing. According to a filing with the Secur...

2026-02-26 17:10:08 ET More on Viatris Viatris Inc. (VTRS) Q4 2025 Earnings Call Transcript Viatris Inc. 2025 Q4 - Results - Earnings Call Presentation Viatris: Deep-Value Pharma With Emerging Growth Catalysts And Strong Cash Generation Viatris beats on Q4; e...

2026-02-26 17:08:13 ET Viatris Inc. (VTRS) Q4 2025 Earnings Call February 26, 2026 8:30 AM EST Company Participants William Szablewski - Head of Investor Relations & Capital Markets Scott Smith - CEO & Director Philippe Martin - Chief R&D Officer ...

2026-02-26 07:30:50 ET More on Viatris Viatris: Deep-Value Pharma With Emerging Growth Catalysts And Strong Cash Generation 44th Annual J.P. Morgan Healthcare Conference Viatris Inc. (VTRS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript ...

2026-02-26 07:06:46 ET More on Viatris Viatris: Deep-Value Pharma With Emerging Growth Catalysts And Strong Cash Generation 44th Annual J.P. Morgan Healthcare Conference Viatris Inc. (VTRS) Presents at 44th Annual J.P. Morgan Healthcare Conference...

2026-02-26 07:01:00 ET More on Viatris Viatris: Deep-Value Pharma With Emerging Growth Catalysts And Strong Cash Generation 44th Annual J.P. Morgan Healthcare Conference Viatris Inc. (VTRS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript ...

Viatris Reports Fourth-Quarter and Full-Year 2025 Financial Results PR Newswire Reports Fourth-Quarter Total Revenues of $ 3.7B and Full-Year 2025 Total Revenues of $ 14.3B Meets or Exceeds 2025 Financial Guidance Across All Key Metrics[1] Returns More Than $1B to Sh...

Viatris Maintains Dividend Policy for 2026 and Announces Quarterly Dividend PR Newswire PITTSBURGH , Feb. 26, 2026 /PRNewswire/ -- Viatris Inc . (Nasdaq: VTRS) today announced that on February 23, 2026, its Board of Directors approved a 2026 dividend policy of 48 cents ($0.48) p...

Evertec Inc. (EVTC) is expected to report $0.81 for Q4 2025 BioCryst Pharmaceuticals Inc. (BCRX) is expected to report $0.06 for Q4 2025 FTI Consulting Inc. (FCN) is expected to report $1.38 for Q4 2025 Arbe Robotics Ltd. (ARBE) is expected to report $-0.1 for Q4 2025 Aclaris Ther...